The expression of IL-7RA in Egyptian patients with multiple sclerosis

被引：0
作者：
Elshafie S. [1 ]
Abdel Rasol H.A. [1 ,2 ]
Helmy H. [3 ]
Younan S. [4 ]
机构：
[1] Clinical and Chemical Pathology Department, Fayoum University, Fayoum
[2] Taibah University, Al Madinah Al Munawara
[3] Neurology Department, Cairo University, Giza
[4] Clinical and Chemical Pathology Department, Ministry of Health, Fayoum
来源：
Comparative Clinical Pathology | 2015年 / 24卷 / 5期
关键词：
IL-7R; Multiple sclerosis;
D O I：
10.1007/s00580-015-2064-5
中图分类号：
学科分类号：
摘要：
Multiple sclerosis has a clinically significant heritable component. The interleukin 7 receptor alpha (IL-7RA) has been recognized as a susceptibility gene for multiple sclerosis (MS). It is known that demographic, environmental factors, as well as population genetic background have a substantial role in multiple sclerosis development. The aim of the present study was to assess the relevance of IL-7RA messenger RNA (mRNA) gene expression level in peripheral blood mononuclear cells (PBMC) on MS phenotype (including clinical and magnetic resonance imaging (MRI) parameters). A total of 31 unrelated Egyptian patients with MS compared to 14 unrelated matched healthy controls were included in the study. IL-7RA VEGF-A gene expression and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a housekeeping gene were measured by real-time polymerase chain reaction (RT-PCR) using SYBR Green technique. IL-7RA mRNA gene expression level was significantly lower in the MS group compared to the control group (p < 0.001). Reduced mRNA IL-7RA expression was observed both in patients with MS compared to the control group and in stratified analysis of MS subtypes: primary progressive MS (PPMS), relapsing progressive MS (RPMS), and secondary progressive MS (SPMS). IL-7RA mRNA gene expression level was not significantly different in MS patients in relapse compared to those in remission (p > 0.05). There was no statistically significant difference in IL-7RA mRNA gene expression level among MS patients with MRI ≥9 brain lesions compared to MS subjects with MRI <9 brain lesions (p > 0.05). IL-7RA mRNA gene expression level cannot be used as a stratifying tool in determining disease course. There was no correlation between IL-7RA mRNA gene expression levels and neither age, age of onset, duration of disease, multiple sclerosis progression index, nor expanded disability status scale. These results confirm the involvement of mRNA gene expression of IL-7RA in MS pathogenesis and suggest that IL-7RA variation may primarily affect chronic disease course. © 2015, Springer-Verlag London.
引用
收藏
页码：1223 / 1230
页数：7
相关论文
共 56 条
[11]  
Erdfeld E., Faul F., Buchner A., GPOWER: a general power analysis program, Behav Res Methods Instrum Comput, pp. 1-11, (1996)
[12]  
Fayad L., Kherlopian A., Abdelnoor A.M., Yamout B., Rahal E.A., Polymorphisms in interleukin-2 and interleukin-7 receptor α-chain genes and human herpes virus-6 as risk factors for multiple sclerosis, Br J Med Med Res, 4, 1, pp. 468-480, (2014)
[13]  
Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., Caillier S.J., Ban M., Goris A., Barcellos L.F., Lincoln R., McCauley J.L., Sawcer S.J., Compston D.A., Dubois B., Hauser S.L., Garcia-Blanco M.A., Pericak-Vance M.A., Haines J.L., Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis, Nat Genet, 39, 9, pp. 1083-1091, (2007)
[14]  
Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., Et al., Risk alleles for multiple sclerosis identified by a genomewide study, N Engl J Med, 357, pp. 851-862, (2007)
[15]  
Halwani R., Doroudchi M., Yassine-Diab B., Janbazian L., Shi Y., Said E.A., Et al., Generation and maintenance of human memory cells during viral infection, Springer Semin Immunopathol, 28, pp. 197-208, (2006)
[16]  
Handunnetthi L., Ramagopalan S.V., Ebers G.C., Multiple sclerosis, vitamin D, and HLA-DRB1*15, Neurology, 74, pp. 1905-1910, (2010)
[17]  
Hare K.J., Jenkinson E.J., Anderson G., An essential role for the IL-7 receptor during intrathymic expansion of the positively selected neonatal T cell repertoire, J Immunol, 165, pp. 2410-2414, (2000)
[18]  
Hartgring S.A., van Roon J.A., Wenting-van Wijk M., Jacobs K.M., Jahangier Z.N., Willis C.R., Et al., Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis, Arthritis Rheum, 60, pp. 2595-2605, (2009)
[19]  
Hauser S.L., Oksenberg J.R., Lincoln R., Garovoy J., Beck R.W., Cole S.R., Et al., Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group, Neurology, 54, pp. 1859-1861, (2000)
[20]  
He Y.W., Malek T.R., Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells, J Exp Med, 184, pp. 289-293, (1996)
123456